Metipranolol Pharmacology of Beta-blocking Agents and Use of Metipranolol in Ophthalmology /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Vienna :
Springer Vienna : Imprint: Springer,
1984.
|
| Edición: | 1st ed. 1984. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-7091-4067-3 |
Tabla de Contenidos:
- New Directions in Glaucoma Therapy - Introductory Speech at the Metipranolol Symposium
- Receptor-mediated Effects of Drugs on the Eye
- Present Day Possibilities of Glaucoma Therapy
- Pharmacological Spectrum of Metipranolol and Experience in Clinical Use
- Suitability of Metipranolol for Glaucoma Therapy from the Pharmacological Viewpoint. Pharmacological Properties of Metipranolol in Glaucoma Therapy
- The Toxicology of Metipranolol with Particular Regard to the Eye
- Principles of Clinical Drug Trials
- The Local Anaesthetic Action of Metipranolol Versus Timolol in Patients with Healthy Eyes
- Pharmaceutical Development of Eye Drops Using the Product Betamann® as an Example
- Results of a 6 Weeks' Multicenter Double-blind Trial Metipranolol Versus Timolol
- Therapeutic Efficacy of Metipranolol Eye Drops 0.3 % Versus Timolol Eye Drops 0.25 % A Double-blind Cross-over Study
- Efficacy and Tolerance of Metipranolol - Results of a Multicenter Long-term Study
- Results of a Long-term Study with Metipranolol
- Metipranolol Eye Drops - Clinical Suitability in the Treatment of Chronic Open Angle Glaucoma
- Prophylaxis of an Iatrogenic Increase in Intraocular Pressure
- Regulating Pressure in Various Forms of Glaucoma with Metipranolol Eye Drops
- Supplementary Comments from the Discussion at the Metipranolol Symposium. Compiled and reviewed.